Cargando…
T189. FREE THYROXIN CONCENTRATIONS MODERATE THE RESPONSE TO A COGNITIVE REMEDIATION THERAPY IN PEOPLE WITH EARLY PSYCHOSIS: PRELIMINARY FINDINGS
BACKGROUND: Cognitive deficits are a common cause of functional disability in people with psychotic disorders. Cognitive remediation produces moderate improvements in cognitive performance in people with schizophrenia, although there is variability in the responses between patients. As previous long...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234418/ http://dx.doi.org/10.1093/schbul/sbaa029.749 |
_version_ | 1783535758200537088 |
---|---|
author | Estrada, Francesc Maria Crosas, Josep Ahuir, Maribel Pérez, Sara Zabala, Wanda Aguayo, Raquel David Barbero, Juan Montalvo, Itziar Tost, Meritxell Llauradó, Laura Guàrdia, Armand Palao, Diego Antonio Monreal, José Labad, Javier |
author_facet | Estrada, Francesc Maria Crosas, Josep Ahuir, Maribel Pérez, Sara Zabala, Wanda Aguayo, Raquel David Barbero, Juan Montalvo, Itziar Tost, Meritxell Llauradó, Laura Guàrdia, Armand Palao, Diego Antonio Monreal, José Labad, Javier |
author_sort | Estrada, Francesc |
collection | PubMed |
description | BACKGROUND: Cognitive deficits are a common cause of functional disability in people with psychotic disorders. Cognitive remediation produces moderate improvements in cognitive performance in people with schizophrenia, although there is variability in the responses between patients. As previous longitudinal studies suggest that free thyroxin (FT4) levels influence attention cognitive tasks in patients with early psychosis, we aimed to conduct a pilot study to explore whether thyroid hormones might predict the response to cognitive remediation therapy (CRT) in patients with first-episode psychosis. METHODS: 27 patients (8 women; 19 men) with first-episode psychosis aged between 18 and 35 years old were randomized to receive a computerized CRT for three months (2 sessions/week) (N=14) or treatment as usual (TAU) (N=13). A full cognitive battery (CANTAB Schizophrenia) was administered at baseline and follow-up (3 months later, after the CRT/TAU period). Plasma levels of thyroid-stimulating hormone (TSH) and FT4 were measured. Data were analyzed on an intention-to-treat basis. Correlation analyses were conducted to explore the association between TSH and FT4 levels and cognitive changes over time. An ANOVA for repeated measures was used to compare longitudinal changes over time by the experimental group while adjusting for TSH and FT4 levels. Significance was defined as p<0.05. RESULTS: TSH concentrations were not associated with cognitive changes over time. FT4 concentrations were associated with cognitive worsening over time in cognitive tasks dealing with reaction time (simple median movement time [r= 0.60, p= 0.003]; simple median reaction time [r= 0.44, p= 0.039]), sustained attention (signal detection for the rapid visual processing task [r= -0.46, p= 0.028]) and verbal memory (immediate recognition [r= -0.54, p= 0.008]; delayed recognition [r= -0.48, p= 0.019]). The ANOVA for repeated measures did not show time by group effects although a time by FT4 significant effect was found for cognitive tasks dealing with these cognitive domains (p<0.05 for all). DISCUSSION: Although a direct effect of the CRT on cognitive improvement was not found, baseline FT4 concentrations appeared to predict the response to CRT in people with early psychosis. Significant associations were found for cognitive domains dealing with attention processes, which are in accordance with previous studies exploring the association between thyroid function and cognitive functioning in early psychotic patients. Our preliminary findings suggest that the determination of thyroid function status might be important for establishing which patients could show cognitive improvements over time. If these results are replicated in larger studies, the determination of thyroid status might help identify those individuals more prone for showing cognitive improvements, and allowing the implementation of a personalized medicine approach in the field of cognitive rehabilitation in psychosis. |
format | Online Article Text |
id | pubmed-7234418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72344182020-05-23 T189. FREE THYROXIN CONCENTRATIONS MODERATE THE RESPONSE TO A COGNITIVE REMEDIATION THERAPY IN PEOPLE WITH EARLY PSYCHOSIS: PRELIMINARY FINDINGS Estrada, Francesc Maria Crosas, Josep Ahuir, Maribel Pérez, Sara Zabala, Wanda Aguayo, Raquel David Barbero, Juan Montalvo, Itziar Tost, Meritxell Llauradó, Laura Guàrdia, Armand Palao, Diego Antonio Monreal, José Labad, Javier Schizophr Bull Poster Session III BACKGROUND: Cognitive deficits are a common cause of functional disability in people with psychotic disorders. Cognitive remediation produces moderate improvements in cognitive performance in people with schizophrenia, although there is variability in the responses between patients. As previous longitudinal studies suggest that free thyroxin (FT4) levels influence attention cognitive tasks in patients with early psychosis, we aimed to conduct a pilot study to explore whether thyroid hormones might predict the response to cognitive remediation therapy (CRT) in patients with first-episode psychosis. METHODS: 27 patients (8 women; 19 men) with first-episode psychosis aged between 18 and 35 years old were randomized to receive a computerized CRT for three months (2 sessions/week) (N=14) or treatment as usual (TAU) (N=13). A full cognitive battery (CANTAB Schizophrenia) was administered at baseline and follow-up (3 months later, after the CRT/TAU period). Plasma levels of thyroid-stimulating hormone (TSH) and FT4 were measured. Data were analyzed on an intention-to-treat basis. Correlation analyses were conducted to explore the association between TSH and FT4 levels and cognitive changes over time. An ANOVA for repeated measures was used to compare longitudinal changes over time by the experimental group while adjusting for TSH and FT4 levels. Significance was defined as p<0.05. RESULTS: TSH concentrations were not associated with cognitive changes over time. FT4 concentrations were associated with cognitive worsening over time in cognitive tasks dealing with reaction time (simple median movement time [r= 0.60, p= 0.003]; simple median reaction time [r= 0.44, p= 0.039]), sustained attention (signal detection for the rapid visual processing task [r= -0.46, p= 0.028]) and verbal memory (immediate recognition [r= -0.54, p= 0.008]; delayed recognition [r= -0.48, p= 0.019]). The ANOVA for repeated measures did not show time by group effects although a time by FT4 significant effect was found for cognitive tasks dealing with these cognitive domains (p<0.05 for all). DISCUSSION: Although a direct effect of the CRT on cognitive improvement was not found, baseline FT4 concentrations appeared to predict the response to CRT in people with early psychosis. Significant associations were found for cognitive domains dealing with attention processes, which are in accordance with previous studies exploring the association between thyroid function and cognitive functioning in early psychotic patients. Our preliminary findings suggest that the determination of thyroid function status might be important for establishing which patients could show cognitive improvements over time. If these results are replicated in larger studies, the determination of thyroid status might help identify those individuals more prone for showing cognitive improvements, and allowing the implementation of a personalized medicine approach in the field of cognitive rehabilitation in psychosis. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7234418/ http://dx.doi.org/10.1093/schbul/sbaa029.749 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Session III Estrada, Francesc Maria Crosas, Josep Ahuir, Maribel Pérez, Sara Zabala, Wanda Aguayo, Raquel David Barbero, Juan Montalvo, Itziar Tost, Meritxell Llauradó, Laura Guàrdia, Armand Palao, Diego Antonio Monreal, José Labad, Javier T189. FREE THYROXIN CONCENTRATIONS MODERATE THE RESPONSE TO A COGNITIVE REMEDIATION THERAPY IN PEOPLE WITH EARLY PSYCHOSIS: PRELIMINARY FINDINGS |
title | T189. FREE THYROXIN CONCENTRATIONS MODERATE THE RESPONSE TO A COGNITIVE REMEDIATION THERAPY IN PEOPLE WITH EARLY PSYCHOSIS: PRELIMINARY FINDINGS |
title_full | T189. FREE THYROXIN CONCENTRATIONS MODERATE THE RESPONSE TO A COGNITIVE REMEDIATION THERAPY IN PEOPLE WITH EARLY PSYCHOSIS: PRELIMINARY FINDINGS |
title_fullStr | T189. FREE THYROXIN CONCENTRATIONS MODERATE THE RESPONSE TO A COGNITIVE REMEDIATION THERAPY IN PEOPLE WITH EARLY PSYCHOSIS: PRELIMINARY FINDINGS |
title_full_unstemmed | T189. FREE THYROXIN CONCENTRATIONS MODERATE THE RESPONSE TO A COGNITIVE REMEDIATION THERAPY IN PEOPLE WITH EARLY PSYCHOSIS: PRELIMINARY FINDINGS |
title_short | T189. FREE THYROXIN CONCENTRATIONS MODERATE THE RESPONSE TO A COGNITIVE REMEDIATION THERAPY IN PEOPLE WITH EARLY PSYCHOSIS: PRELIMINARY FINDINGS |
title_sort | t189. free thyroxin concentrations moderate the response to a cognitive remediation therapy in people with early psychosis: preliminary findings |
topic | Poster Session III |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234418/ http://dx.doi.org/10.1093/schbul/sbaa029.749 |
work_keys_str_mv | AT estradafrancesc t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT mariacrosasjosep t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT ahuirmaribel t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT perezsara t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT zabalawanda t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT aguayoraquel t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT davidbarberojuan t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT montalvoitziar t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT tostmeritxell t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT llauradolaura t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT guardiaarmand t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT palaodiego t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT antoniomonrealjose t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings AT labadjavier t189freethyroxinconcentrationsmoderatetheresponsetoacognitiveremediationtherapyinpeoplewithearlypsychosispreliminaryfindings |